Elevated Apo B levels in ASCVD patients probably indicate an increased burden of atherogenic particles, which is correlated with increased cardiovascular risk.38 Concurrently, a higher Apo B/A1 ratio suggests an imbalance favouring atherogenic particles over antiatherogenic particles, highlighting an adverse lipid profile in the ASCVD group.16 Here, APOB is linked to atherosclerosis.